Overturning of Molecular Test Coverage Denials Varies Widely, According to UCSF Study
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns
The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture
The technology developed by Roche in recent years seems a good fit for Labcorp’s testing services
Third-party verification of lab personnel experience is now a CLIA requirement
Bill that ended government shutdown includes provision to hold off PAMA cuts
How clinical laboratories should prepare for the next wave of oversight in the new year
Australian firm has grown its overseas operations dramatically in the past decade, except in America
However, clinical laboratories may have more say in future laws and guidance thanks to 2024 decision
Roche’s vitamin D assay includes internal quality controls that allowed it to obtain the CLIA designation
The lab giant and the Michigan health system will build a 100,000-square-foot lab as part of a new business
The assay was widely used during the early months of COVID-19 and was a significant source of revenue growth for a time